Short answer
SBC Medical Group Holdings Inc (SBC) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Fiscal quarter ended June 30, 2026 results released August 13, 2026.
SBC Medical Group Holdings Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal quarter ended June 30, 2026 results released August 13, 2026
- Press release contains the financial results and operating commentary
- Investors should review Exhibit 99.1 for reported figures and management outlook
Item 7.01 · Regulation FD Disclosure
- 2Q 2026 investor presentations posted August 13, 2026
- Materials cover business overview and results for quarter ended June 30, 2026
- Company identifies website disclosures as potentially material to investors
- Investors directed to monitor website alongside SEC filings, releases, calls, webcasts, and LinkedIn
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $49M, up 13% YoY, signaling growth reacceleration after 2025 restructuring
- Net income attributable to SBC Medical $11M, up 335%, with margin expanding to 22% from 6%
- Adjusted EBITDA $20M, up 32%, while margin rose to 41% from 35%
- Network locations reached 287, up 34 YoY, with visits up 10% and average spend per visit up 9%
- Planned fee revisions could add approximately $15M in annual service fees if fully realized
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SBC Medical Group Holdings Inc 8-K filings
Get the next SBC 8-K as it lands
Follow SBC for push alerts, or ask the research agent what this filing means.